Orphazyme is now officially in American hands

The sale of embattled biotech firm Orphazyme to US-based Kempharm is now complete.

Photo: Orphazyme/PR

Orphazyme has announced that the sale of the firm and all of its assets to Kempharm is now complete.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs